Chengdu Kanghua Biological Products (300841) — Strategic Asset Allocation Index
Chengdu Kanghua Biological Products (300841) has a Strategic Asset Allocation Index of 28.2% as of September 2023. Strategic assets (PP&E of CN¥954.01 Million plus long-term investments of CN¥-) total CN¥954.01 Million, measured against net assets of CN¥3.38 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See 300841 net asset quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Chengdu Kanghua Biological Products Strategic Asset Allocation Index (2017–2022)
This chart shows how Chengdu Kanghua Biological Products's Strategic Asset Allocation Index has evolved across 6 annual periods from 2017 to 2022. As of September 2023, the index stands at 28.2%, representing strategic assets of CN¥954.01 Million against net assets of CN¥3.38 Billion CNY. For live market cap and overall valuation, see how much is Chengdu Kanghua Biological Products worth.
Annual Strategic Asset Allocation Index for Chengdu Kanghua Biological Products (2017–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Chengdu Kanghua Biological Products from 2017 to 2022, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See what is Chengdu Kanghua Biological Products's book value for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 32.0% | CN¥985.45 Million | CN¥985.45 Million | CN¥- | CN¥3.08 Billion | ▲ +13.7 pp |
| 2021 | 18.3% | CN¥488.72 Million | CN¥488.72 Million | CN¥- | CN¥2.67 Billion | ▲ +8.1 pp |
| 2020 | 10.2% | CN¥202.13 Million | CN¥202.13 Million | CN¥- | CN¥1.97 Billion | ▼ -3.7 pp |
| 2019 | 13.9% | CN¥79.85 Million | CN¥79.85 Million | CN¥- | CN¥574.65 Million | ▼ -8.2 pp |
| 2018 | 22.1% | CN¥81.11 Million | CN¥81.11 Million | CN¥- | CN¥367.70 Million | ▼ -4.9 pp |
| 2017 | 27.0% | CN¥50.82 Million | CN¥50.82 Million | CN¥- | CN¥188.37 Million | — |